Palvella Therapeutics (NasdaqCM:PVLA) Earnings Call Presentation
2025-09-24 12:30
First-in-disease therapies for patients with rare skin diseases QTORIN Rapamycin Pipeline Expansion September 24, 2025 1 Forward Looking Statements This presentation contains forward-looking statements of Palvella Therapeutics, Inc. (the Company") within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements include all statements that are not historical facts, and in some cases, can be identified by terms such as "may," "might," "will," "could," "would," "should," ...